Oncogenic mutations within the β3‐αC loop of EGFR/ERBB2/BRAF/MAP2K1 predict response to therapies
Abstract Background β3‐αC loop is a highly conserved structural domain across oncogene families, which is a switch for kinase activity. There have been numerous researches on mutations within β3‐αC loop in EGFR, but relatively less in ERBB2, BRAF, and MAP2K1. In addition, previous studies mainly foc...
Main Authors: | Biao Zhang, Yongsheng Chen, Pingping Dai, Haoda Yu, Jianhui Ma, Chen Chen, Yan Zhang, Yanfang Guan, Rongrong Chen, Tao Liu, Jiayin Wang, Ling Yang, Xin Yi, Xuefeng Xia, Haitao Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1395 |
Similar Items
-
The Role of c-erbB-2 Oncogene in Breast Carcinoma
by: Seyda Erdogan, et al.
Published: (2003-06-01) -
Oncogenic BRAF-Mediated Melanoma Cell Invasion
by: Hezhe Lu, et al.
Published: (2016-05-01) -
Activating Mutations and/or Expression Levels of Tyrosine Kinase Receptors GRB7, RAS, and BRAF in Testicular Germ Cell Tumors
by: Alan McIntyre, et al.
Published: (2005-12-01) -
Targeting Oncogenic BRAF: Past, Present, and Future
by: Aubhishek Zaman, et al.
Published: (2019-08-01) -
Alterations of c-Myc and c-erbB-2 genes in ovarian tumours
by: Pastor Tibor, et al.
Published: (2009-01-01)